As such, the FXR agonist INT747 improves insulin sensitivity and liver function in humans [133], whereas another FXR agonist (WAY-362450) attenuates liver inflammation and fibrosis in a mouse model of fatty liver [134]. The gene discussed is NR1H4; the disease is Hepatic steatosis.